Viewing Study NCT00559650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2026-01-29 @ 8:22 AM
Study NCT ID: NCT00559650
Status: TERMINATED
Last Update Posted: 2017-04-18
First Post: 2007-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congestive Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute decompensated heart failure View
None Double blind study, View
None BAY58-2667 View
None Soluble guanylate cyclase activator View